Phase 2 Safety and Efficacy Study Evaluating Glutamic Acid Decarboxylase Gene Transfer to Subthalamic Nuclei in Subjects With Advanced Parkinson's Disease
Phase of Trial: Phase II
Latest Information Update: 12 Dec 2018
At a glance
- Drugs NLX P101 (Primary)
- Indications Parkinson's disease
- Focus Adverse reactions; Therapeutic Use
- Sponsors Neurologix
- 12 Dec 2018 Results presented in a MeiraGTx media release.
- 12 Dec 2018 According to a MeiraGTx media release, results from this study were published in the 2018 issue of Science Translational Medicine.
- 09 Oct 2018 According to a MeiraGTx media release, results of this trial were published in the August 2014 issue of Journal of Clinical Investigation and the April 2017 issue of JCI Insight.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History